ARCH Venture Partners vs Foresite Capital
Two firms that co-invest: side by side on stage, sector, check size, and track record, from public filings and the firms' own sites.
| ARCH Venture Partners | Foresite Capital | |
|---|---|---|
| Type | Venture capital | Venture capital |
| HQ | Chicago | Larkspur |
| Founded | 1989 | 2011 |
| Check size | $50K – $250M | — |
| Stages | Seed, Series A, Series B, Series C, Growth | Pre-Seed, Seed, Series A, Series B, Series C, Growth, Late Stage |
| Sectors | Biotech, Deep Tech, Healthtech | AI & Machine Learning, Biotech, Digital Health, Healthtech, Longevity, Medical Devices |
| AUM | $12B | $3.2B |
| Tracked investments | 144 | 186 |
| Exits (acquired/public) | 6 | 1 |
| Led rounds on record | 3 | — |
| Dated deals, last 24 mo | 10 | 4 |
Shared portfolio · 12
Beam TherapeuticsBit BioDenali TherapeuticsGRAILInsitroKura OncologyMaze TherapeuticsParabilis MedicinesRemix TherapeuticsSeaport TherapeuticsXaira TherapeuticsLyell Immunopharma
Frequently asked questions
- Do ARCH Venture Partners and Foresite Capital invest together?
- Yes — ARCH Venture Partners and Foresite Capital appear together in 12 tracked portfolio companies, including Beam Therapeutics, Bit Bio, Denali Therapeutics, GRAIL, Insitro.